The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2007

Filed:

Sep. 30, 2004
Applicants:

Patrick Mailliet, Fontenay sous Bois, FR;

Jean-francois Riou, Reims, FR;

Marcel Alasia, Choisy le Roi, FR;

Thomas Caulfield, Paris, FR;

Gilles Doerflinger, Les Ulis, FR;

Jean-louis Mergny, Villejuif, FR;

Abdelazize Laoui, Bridgewater, NJ (US);

Odile Petitgenet, Paris, FR;

Emmanuelle Renou, Paris, FR;

Inventors:

Patrick Mailliet, Fontenay sous Bois, FR;

Jean-Francois Riou, Reims, FR;

Marcel Alasia, Choisy le Roi, FR;

Thomas Caulfield, Paris, FR;

Gilles Doerflinger, Les Ulis, FR;

Jean-Louis Mergny, Villejuif, FR;

Abdelazize Laoui, Bridgewater, NJ (US);

Odile Petitgenet, Paris, FR;

Emmanuelle Renou, Paris, FR;

Assignee:

Aventis Pharma S.A., Antony, FR;

Attorneys:
Int. Cl.
CPC ...
C07D 239/50 (2006.01); C07D 213/02 (2006.01); C07D 215/38 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which inhibits telomerase. It also relates to novel chemical compounds as well as their therapeutic application in humans.


Find Patent Forward Citations

Loading…